China Resources Double Crane (600062.SH): Compound Sodium Chloride Injection of Telmisartan Hydrochloride obtained Drug Registration Certificate

The Zhitong Financial APP News reported that Huaren Shuanghe (600062.SH) has issued an announcement. Recently, the company's wholly-owned subsidiary, Anhui Shuanghe Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Shuanghe"), received the "Drug Registration Certificate" for the hydrochloride telmisartan sodium chloride injection (hereinafter referred to as "the drug") issued by the National Medical Products Administration.